GO
Loading...

Health Care Equipment and Supplies

More

  • Final Glance: Medical Devices companies Thursday, 11 Dec 2014 | 6:02 PM ET

    Allergan rose $1.04 or. 5 percent, to $211.14. Baxter International Inc. rose$. 35 or. 5 percent, to $73.11. Boston Scientific Corp. rose$. 29 or 2.3 percent, to $12.89.

  • Midday Glance: Medical Devices companies Thursday, 11 Dec 2014 | 1:19 PM ET

    Allergan rose $1.01 or. 5 percent, to $211.11. Baxter International Inc. rose$. 48 or. 7 percent, to $73.24. Boston Scientific Corp. rose$. 24 or 1.9 percent, to $12.84.

  • Early Glance: Medical Devices companies Thursday, 11 Dec 2014 | 11:28 AM ET

    Allergan rose $1.18 or. 6 percent, to $211.29. Baxter International Inc. rose$. 59 or. 8 percent, to $73.35. Boston Scientific Corp. rose$. 09 or. 7 percent, to $12.69.

  • Final Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Allergan fell $2.30 or 1.1 percent, to $210.10. Baxter International Inc. fell $1.03 or 1.4 percent, to $72.76. Boston Scientific Corp. fell$. 44 or 3.4 percent, to $12.60.

  • Midday Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Allergan fell $1.33 or. 6 percent, to $211.07. Baxter International Inc. fell$. 39 or. 5 percent, to $73.40. Boston Scientific Corp. fell$. 22 or 1.6 percent, to $12.83.

  • Early Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Allergan fell$. 68 or. 3 percent, to $211.72. Baxter International Inc. fell$. 08 or. 1 percent, to $73.71. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.90.

  • Final Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 6:10 PM ET

    Allergan fell$. 16 or. 1 percent, to $212.40. Baxter International Inc. fell$. 33 or. 4 percent, to $73.79. Boston Scientific Corp. rose$. 10 or. 8 percent, to $13.04.

  • Fighting hospital-visit infections with LED lights Tuesday, 9 Dec 2014 | 3:59 PM ET
    Colleen Costello (R) and James Peterson.

    Two young engineers invented a product that uses LED lights to fight bacteria and decrease risk of infections in hospitals and public spaces.

  • Midday Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 1:21 PM ET

    Allergan fell$. 94 or. 4 percent, to $211.62. Baxter International Inc. fell$. 74 or 1.0 percent, to $73.38. Boston Scientific Corp. rose$. 05 or. 4 percent, to $12.99.

  • Early Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 10:21 AM ET

    Allergan fell $1.07 or. 5 percent, to $211.49. Baxter International Inc. fell$. 61 or. 8 percent, to $73.51. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.89.

  • Final Glance: Medical Devices companies Monday, 8 Dec 2014 | 6:02 PM ET

    Allergan fell$. 79 or. 4 percent, to $212.56. Baxter International Inc. fell$. 10 or. 1 percent, to $74.12. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.94.

  • Walgreen tests virtual doctor visits through app Monday, 8 Dec 2014 | 3:11 PM ET

    Walgreen is testing a new telemedicine service that lets patients see a doctor without leaving home or visiting any of the drugstore chain's clinics. The Deerfield, Illinois, company said Monday that patients in California or Michigan can now contact a physician around the clock through Walgreen's mobile application for smartphones or tablet computers.

  • Dec 8- Medical device maker Stryker Corp will pay the U.S. government $80 million to settle criminal and civil charges that its OtisMed Corp subsidiary sold devices used in knee replacement surgery without approval from the U.S. Food and Drug Administration. The company sold more than 18,000 OtisKnee cutting guides- which are designed to help surgeons make...

  • Dec 8- Medical device maker Stryker Corp will pay the U.S. government $80 million to settle charges that its OtisMed Corp subsidiary sold devices used in knee replacement surgery without approval from the U.S. Food and Drug Administration. The company sold more than 18,000 OtisKnee cutting guides- which are designed to help surgeons make accurate bone cuts in...

  • Stryker will pay about $80M to end investigation Monday, 8 Dec 2014 | 1:27 PM ET

    NEW YORK— The medical device maker Stryker will pay about $80 million to end a federal investigation into its acquisition of a company that the U.S. said was marketing a product that hadn't been approved by regulators. The company said that the U.S. Department of Justice acknowledged that the sales occurred before Stryker bought OtisMed in 2009, and that it was...

  • Midday Glance: Medical Devices companies Monday, 8 Dec 2014 | 1:20 PM ET

    Allergan fell$. 15 or. 1 percent, to $213.20. Baxter International Inc. fell$. 01 or percent, to $74.21. Medtronic fell$. 03 or percent, to $75.01.

  • Early Glance: Medical Devices companies Monday, 8 Dec 2014 | 10:22 AM ET

    Allergan rose$. 39 or. 2 percent, to $213.74. Baxter International Inc. rose$. 13 or. 2 percent, to $74.35. Boston Scientific Corp. rose$. 01 or. 1 percent, to $12.92.

  • BlackBerry, NantHealth launch cancer genome browser Sunday, 7 Dec 2014 | 10:44 PM ET

    TORONTO, Dec 7- BlackBerry Ltd and NantHealth, a healthcare-focused data provider, launched a secure cancer genome browser on Sunday, giving doctors the ability to access patients' genetic data on the BlackBerry Passport smartphone. "Our partnership with BlackBerry has really been able to create a scalable super-computer in the palm of the hands of the doctor,"...

  • The figure represents the average premium for the second-lowest-cost silver plan, which is the benchmark plan used to set subsidy levels, the Department of Health and Human Services said. The report from its Office of the Assistant Secretary for Planning and Evaluation covered the costs of plans sold on the website run by the federal government and created...

  • Dec 4- The top U.S. patent appeals court has thrown out a $176 million award for healthcare company Covidien Plc in a dispute with a Johnson& Johnson subsidiary over surgical instruments. Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., ruled on Thursday that Covidien's patent claims, which involve surgical cutting tools...